John Hopper, MBA Corporate Treasurer, SARC Founding Co-Chair of the GI Cancers Alliance, Founding Co-Chair of NORD Rare Cancer Coalition, President Emeritus of the Fibrolamellar Cancer Foundation John Hopper is the Founding Co-Chair of the GI Cancers Alliance, Founding Co-Chair of NORD (National Organization Rare Disorders) Rare Cancer Coalition, President Emeritus of the Fibrolamellar Cancer Foundation, member of the Chan Zuckerberg Initiative (CZI) Rare as One Network and Former Board Director of the National Pancreas Foundation. Prior to his focus on health care foundations, John created and led multibillion dollar revenue centers as well as start-ups and turn-arounds across numerous industry verticals with emphasis in health/wellness, digital/interactive, consumer goods, environment, and technology both nationally and internationally. John launched profitable divisions and products for such companies as the WPP Group, Interpublic (IPG), Unilever, P&G and Publicis and spearheaded complex international cross-discipline management teams. He has held various board positions within digital companies as well as co-founding wellness venture capital and renewable energy mobilization firms. His experience also includes: Adjunct Professor, NYU Stern Graduate School of Business, US Department of Defense – Pancreatic Cancer Research Advisory Board; National Cancer Institute (NIH/NCI) Small Business Advisor Board and MyPART; State of Connecticut Business Health Council- Office of Secretary of State; University of Connecticut – Environmental Health Academic Internship leader Hopper is a graduate of the College of the Holy Cross, and the Unilever/Oxford Executive MBA program. Believing in a purposeful life, in 2020 John and his three children launched the Hopper-Belmont Foundation which annually recognizes exceptional early career cancer investigators with their Inspiration Award. John is the SARC Corporate Treasurer and Chair of the SARC Finance Committee.